Kingworld Medicines Group Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kingworld Medicines Group Limited with three other
drug stores in Asia:
of South Korea
sales of 98.45 billion Korean Won [US$87.52 million]
Qianhai Health Holdings Limited
of Hong Kong
(835.53 million Hong Kong Dollars [US$107.68 million]
of which 86%
was Cultivated ginseng), and
China NT Pharma Group Co Ltd
(847.73 million Chinese Renmimbi [US$125.76 million]
of which 74%
was Third-party Pharnaceutical Promotion & S).
Kingworld Medicines Group Limited reported sales of 713.55 million Chinese Renmimbi (US$105.85 million)
December of 2015.
increase of 8.1%
versus 2014, when the company's sales were 660.32 million Chinese Renmimbi.